🇺🇸 From United States · Cardiology · Cardiac surgery
Coronary disease treatment in China for United States patients
End-to-end pathway: visa, flight, hospital match, cost and length of stay — tailored for patients travelling from United States for coronary disease care.
Pathway at a glance
About coronary disease
Coronary artery disease is the leading cause of death globally and accumulates risk over decades. Modern care spans primary prevention (statins, BP control, lifestyle), secondary prevention after events, and intervention (PCI, CABG). China's cardiac centres — anchored by Fuwai NCCD with one of the highest cardiac surgery volumes globally — deliver world-class care at substantially lower cost.
Why United States patients travel to China
US patients typically come for: stem cell and regenerative medicine (unavailable / restricted at home), CAR-T cellular immunotherapy (one-third the US price), proton therapy, orthopedic surgery, and high-end executive physicals.
Recommended cities for United States patients
Beijing (PUMC International) and Shanghai (Ruijin VIP, SUFH) have the strongest English-speaking infrastructure for US patients. Shenzhen (HKU-SZ, Shenzhen United Family) for stem cell, dental and English-first care.
Diagnostic workup at Class A centres
- Comprehensive lipid panel including ApoB and (once in lifetime) Lp(a)
- HbA1c, fasting glucose, BP measurement
- ECG; echocardiogram in selected patients
- Coronary artery calcium (CAC) score for intermediate-risk patients
- Coronary CT angiography (CTA) for symptomatic patients
- Stress imaging or coronary angiography in advanced cases
Workup cost band: $280–$540 USD.
Treatment options
Lifestyle modification
first-lineDiet, exercise, sleep, smoking cessation — foundational across all stages.
Statin therapy
first-lineFirst-line lipid-lowering. PCSK9 inhibitors and ezetimibe for higher-risk or insufficiently controlled patients.
Antiplatelet therapy
first-lineAspirin, P2Y12 inhibitors per indication.
Percutaneous coronary intervention (PCI)
selected casesStenting for acute coronary syndromes, refractory angina with appropriate anatomy. Drug-eluting stents standard.
Coronary artery bypass grafting (CABG)
selected casesSurgical revascularisation for left main disease, three-vessel disease (especially with diabetes or reduced LV function), and selected complex cases. Off-pump and minimally invasive options available.
Cardiac rehabilitation
first-lineStrong evidence for mortality and morbidity reduction post-event. Available at academic cardiac centres.
Procedure cost from United States
| Procedure | China (USD) | United States (USD) | Length of stay |
|---|---|---|---|
| CABG | 22,000 – 35,000 | 100,000 – 200,000 | 21–28 d |
Visa pathway for United States patients
Fingerprinting required (in person, since 2019). 10-year multi-entry M-visa is standard for medical patients, valuable for follow-up trips.
- 1
Receive invitation letter
Panda Touring Care sends you the hospital invitation letter and appointment confirmation within 3–5 business days of confirming your case.
- 2
Complete visa form online
Fill the COVA online application at cova.cs.mfa.gov.cn. Print the completed form and confirmation page. Allow 30–45 minutes.
- 3
Book CVASC appointment
Schedule biometric appointment at your nearest Chinese Visa Application Service Center (NYC, DC, Chicago, SF, LA, Houston). Walk-in availability varies.
- 4
Submit application in person
Bring all documents + passport + photo. Fingerprinting takes 5–10 minutes. Pay fees in cash or card. Receive collection slip with pickup date.
- 5
Collect visa
Pick up passport with M-visa 5–10 business days later (or 2–3 days expedited). Most CVASCs allow proxy pickup with authorisation letter.
Frequently asked
- Do United States patients need a visa for coronary disease treatment in China?
- Yes — United States citizens require M-Visa for medical treatment in China. Processing: 5–10 business days standard · 2–3 days expedited. Fee: $185 application + $5 visa book. Validity: Up to 10 years multi-entry (most common).
- How long is the flight from United States to China?
- 13–16 hours direct (LAX/SFO/ORD/JFK)
- Which Chinese cities are best for United States patients seeking coronary disease care?
- Beijing (PUMC International) and Shanghai (Ruijin VIP, SUFH) have the strongest English-speaking infrastructure for US patients. Shenzhen (HKU-SZ, Shenzhen United Family) for stem cell, dental and English-first care.
- How much can United States patients save on coronary disease treatment in China?
- Typical Class A all-in pricing in China: $22,000–$35,000 USD. Equivalent in United States: $100,000–$200,000 USD. Savings before travel: roughly 65–89%.
- What's the diagnostic workup for coronary disease at Class A international departments?
- Comprehensive lipid panel including ApoB and (once in lifetime) Lp(a); HbA1c, fasting glucose, BP measurement; ECG; echocardiogram in selected patients; Coronary artery calcium (CAC) score for intermediate-risk patients; Coronary CT angiography (CTA) for symptomatic patients; Stress imaging or coronary angiography in advanced cases.
Plan your coronary disease treatment from United States
We arrange visa support, hospital match, written quote and door-to-door logistics from United States. No obligation.